Antibody drug may cut Covid-19 hospitalizations, company says

  • 📰 NBCNews
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 86%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

Antibody drug may cut Covid-19 hospitalizations, company says.

They are being tested to treat newly diagnosed Covid-19 patients in hope of preventing serious disease or death, and to try to prevent infection in people at high risk of that such as nursing home residents and health workers.

The company felt that giving the actual numbers"told the story in the most balanced way,” said Lilly’s chief scientific officer, Dr. Daniel Skovronsky. The study will continue to test the antibody drug in combination with another from a Chinese company, Junshi Biosciences.also are underway, including two sponsored by the U.S. National Institutes of Health.

 

コメントありがとうございます。コメントは審査後に公開されます。

Watch 'Heated Vaccine Debate - Kennedy Jr. vs Dershowitz' on YouTube

TRUST THE SCIENCE. LISTEN TO THE EXPERTS.

In 2008, Michael Greger, MD, physician,internationally recognized expert on public health issues discussed worst pandemics in history, and how to treat the cause by preventing the emergence of pandemic viruses in the first place.

Incredible.

There's various nano antibody efforts and the best really deserve support/coverage

Saying is easy doing is hard and can be confirmed in a transparent society

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 10. in JP

日本 最新ニュース, 日本 見出し